1-9 of 9
David Bareford
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Symptom Burden Among PV and ET Patients Receiving A Novel Histone Deacetylase Inhibitor: Findings From a Open-Label Phase II Study

Christen Lykkegaard Andersen, MD, Mary Frances McMullin, MD, MRCPath, Robyn M. Emanuel, MD, MPH, Amylou C. Dueck, PhD, David Bareford, MD, Claire N Harrison, DM FRCP FRCPath, Hans Hansselbalch, Steven Knapper, MD, Holly Lynn Geyer, MD, Ruben A. Mesa
Journal: Blood
Blood (2012) 120 (21): 1736.
https://doi.org/10.1182/blood.V120.21.1736.1736
Published: 2012
Journal Articles

A Phase II Study of Vorinostat (MK-0683) in Patients with Polycythemia Vera and Essential Thrombocythemia

Christen Lykkegaard Andersen, MD, Mary Frances McMullin, MD, Elisabeth Ejerblad, MD, Sonja Zweegman, MD, PhD, Claire N Harrison, DM FRCP FRCPath, Savio Fernandes, MD, David Bareford, MD, Steven Knapper, MD, Jan Samuelsson, MD, Eva Löfvenberg, MD, Olle Linder, MD, Bjørn Andreasson, MD, Erik Ahlstrand, MD, Morten K. Jensen, MD, Ole Weis Bjerrum, MD, Hanne Vestergaard, MD, Herdis Larsen, MD, Tobias Wirenfeldt Klausen, Torben mourits-Andersen, MD, Hans Hasselbalch, MD
Journal: Blood
Blood (2012) 120 (21): 803.
https://doi.org/10.1182/blood.V120.21.803.803
Published: 2012
Journal Articles

Two routes to leukemic transformation after a JAK2 mutation–positive myeloproliferative neoplasm

Philip A. Beer, François Delhommeau, Jean-Pierre LeCouédic, Mark A. Dawson, Edwin Chen, David Bareford, Rajko Kušec, Mary Frances McMullin, Claire N. Harrison, Alessandro M. Vannucchi, William Vainchenker, Anthony R. Green
Journal: Blood
Blood (2010) 115 (14): 2891–2900.
https://doi.org/10.1182/blood-2009-08-236596
Published: 2010
Journal Articles

MPL mutations in myeloproliferative disorders: analysis of the PT-1 cohort

Philip A. Beer, Peter J. Campbell, Linda M. Scott, Anthony J. Bench, Wendy N. Erber, David Bareford, Bridget S. Wilkins, John T. Reilly, Hans C. Hasselbalch, Richard Bowman, Keith Wheatley, Georgina Buck, Claire N. Harrison, Anthony R. Green
Journal: Blood
Blood (2008) 112 (1): 141–149.
https://doi.org/10.1182/blood-2008-01-131664
Published: 2008
Includes: Supplemental data
Journal Articles

Bone marrow pathology in essential thrombocythemia: interobserver reliability and utility for identifying disease subtypes

Clinical Trials & Observations
Bridget S. Wilkins, Wendy N. Erber, David Bareford, Georgina Buck, Keith Wheatley, Clare L. East, Beverley Paul, Claire N. Harrison, Anthony R. Green, Peter J. Campbell
Journal: Blood
Blood (2008) 111 (1): 60–70.
https://doi.org/10.1182/blood-2007-05-091850
Published: 2008
Journal Articles

Clinical Significance of MPL Mutations in Essential Thrombocythemia: Analysis of the PT-1 Cohort.

Philip Beer, Peter Campbell, Wendy Erber, Linda Scott, Anthony Bench, David Bareford, Wilkins Bridget, Keith Wheatley, Georgina Buck, Claire Harrison, Anthony Green
Journal: Blood
Blood (2007) 110 (11): 677.
https://doi.org/10.1182/blood.V110.11.677.677
Published: 2007
Journal Articles

JAK2 V617F Mutation Identifies a Biologically Distinct Subtype of Essential Thrombocythemia Which Resembles Polycythemia Vera.

Anthony Green, Peter Campbell, Linda Scott, Georgina Buck, Keith Wheatley, Clare East, Joanne Marsden, Audrey Duffy, Elaine Boyd, Anthony Bench, Mike Scott, George Vassiliou, Don Milligan, Steve Smith, Wendy Erber, David Bareford, Bridget Wilkins, John Reilly, Claire Harrison
Journal: Blood
Blood (2005) 106 (11): 253.
https://doi.org/10.1182/blood.V106.11.253.253
Published: 2005
Journal Articles

The Medical Research Council PT1 Trial in Essential Thrombocythemia.

Anthony Green, Peter Campbell, Georgina Buck, Keith Wheatley, Clare East, David Bareford, Bridget Wilkins, Jon Van der Walt, John Reilly, Claire Harrison
Journal: Blood
Blood (2004) 104 (11): 6.
https://doi.org/10.1182/blood.V104.11.6.6
Published: 2004
Journal Articles

Randomized comparison of low-dose versus high-dose interferon-alfa in chronic myeloid leukemia: prospective collaboration of 3 joint trials by the MRC and HOVON groups

Clinical Trials & Observations
Hanneke C. Kluin-Nelemans, Georgina Buck, Saskia le Cessie, Sue Richards, H. Berna Beverloo, J. H. Frederik Falkenburg, Tim Littlewood, Petra Muus, David Bareford, Hans van der Lelie, Anthony R. Green, Klaas J. Roozendaal, Alison E. Milne, Claire S. Chapman, Patricia Shepherd, for the UK CML Working Group of NCRI and the HOVON trials group
Journal: Blood
Blood (2004) 103 (12): 4408–4415.
https://doi.org/10.1182/blood-2003-10-3605
Published: 2004